Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MeReC Bulletin - Rheumatoid Arthritis

The National Prescribing Centre has published a MeReC Bulletin (PDF)that provides an update on drug treatment in rheumatoid arthritis.

The bulletin provides a brief introduction into the early diagnosis of the disease and covers the place in therapy for disease modifying anti-rheumatic drugs (DMARDs), biologic agents and corticosteroids.

In addition, combination therapy is also discussed as well as consideration of the safety issues around methotrexate, monitoring of DMARDs and biologic agents and how to limit corticosteroid-induced osteoporosis.

Perhaps the most valuable part of this Bulletin is the summary table of recommendations for monitoring for adverse effects from DMARDs and biologic therapies.

Action: Clinicians involved in the diagnosis and treatment of rheumatoid arthritis, or in the monitoring of drug therapy, will find this bulletin useful and informative.

Share 'MeReC Bulletin - Rheumatoid Arthritis' on Email Share 'MeReC Bulletin - Rheumatoid Arthritis' on Delicious Share 'MeReC Bulletin - Rheumatoid Arthritis' on Digg Share 'MeReC Bulletin - Rheumatoid Arthritis' on Facebook Share 'MeReC Bulletin - Rheumatoid Arthritis' on Google+ Share 'MeReC Bulletin - Rheumatoid Arthritis' on reddit Share 'MeReC Bulletin - Rheumatoid Arthritis' on StumbleUpon Share 'MeReC Bulletin - Rheumatoid Arthritis' on Twitter

atomic-wealth

No Comments to “MeReC Bulletin - Rheumatoid Arthritis”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,781 spam comments.

atomic-wealth
fond-illness
summer